Skip to Main Content

Author Details

Alastair J J Wood
Vanderbilt University
1974
261
68
PMIDPaper TitleJournal TitlePublished Year
32134427Regulating Medicines in a Globalized World With Increased Recognition and Reliance Among Regulators: A National Academies Report.JAMA2020
31260791Rationale and design of the regimen education and messaging in diabetes (REMinD) trial.Contemp Clin Trials2019
28823927Development and rationale for a multifactorial, randomized controlled trial to test strategies to promote adherence to complex drug regimens among older adults.Contemp Clin Trials2017
27542666A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence.J Gen Intern Med2016
25611663In reply.Anesthesiology2015
24694922Comparative analysis of outcome measures used in examining neurodevelopmental effects of early childhood anesthesia exposure.Anesthesiology2014
23511785If you don't know where you are going, you can't tell if you have arrived: defining goals for drug safety announcements.Clin Pharmacol Ther2013
23873118Variation in the α(2A) adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose.Pharmacogenet Genomics2013
22168588The politics of emergency contraception.N Engl J Med2012
23047355The need for rigorous evidence on medication use in preterm infants: is it time for a neonatal rule?JAMA2012
22908104Long-term differences in language and cognitive function after childhood exposure to anesthesia.Pediatrics2012
22271297CYP2A6 genetic variation and dexmedetomidine disposition.Eur J Clin Pharmacol2012
22258110Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise.Pharmacogenet Genomics2012
21150800Effect of standardized, patient-centered label instructions to improve comprehension of prescription drug use.Med Care2011
21684281The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome.Gastroenterology2011
21325151Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine.Circ Cardiovasc Genet2011
21357804Helping patients simplify and safely use complex prescription regimens.Arch Intern Med2011
21045729Independent regulation of α1 and α2 adrenergic receptor-mediated vasoconstriction in vivo.J Hypertens2011
19423370Effects of variation in the human alpha2A- and alpha2C-adrenoceptor genes on cognitive tasks and pain perception.Eur J Pain2010
20647188Don't mess with the DSMB.N Engl J Med2010
20051907Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype.J Hypertens2010
19228628Progress and deficiencies in the registration of clinical trials.N Engl J Med2009
19923560Industry influence on comparative-effectiveness research funded through health care reform.N Engl J Med2009
19842931GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans.Pharmacogenomics2009
19624360Intraoperative reported adverse events in children.Paediatr Anaesth2009
19776395Risk of confusion in dosing Tamiflu oral suspension in children.N Engl J Med2009
19444546The alpha2C-adrenoceptor deletion322-325 variant and cold-induced vasoconstriction.Clin Auton Res2009
18071056Ethnic and genetic determinants of cardiovascular response to the selective alpha 2-adrenoceptor agonist dexmedetomidine.Hypertension2008
18794726Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.Pharmacogenet Genomics2008
18946281Anesthesia and neurodevelopment in children: time for an answer?Anesthesiology2008
19034106Tariquidar, a selective P-glycoprotein inhibitor, does not potentiate loperamide's opioid brain effects in humans despite full inhibition of lymphocyte P-glycoprotein.Anesthesiology2008
18698227Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses.Pharmacogenet Genomics2008
18434649Playing "kick the FDA"--risk-free to players but hazardous to public health.N Engl J Med2008
17351367Effect of the alpha2C-adrenoreceptor deletion322-325 variant on sympathetic activity and cardiovascular measures in healthy subjects.J Hypertens2007
17301734The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud's phenomenon.Clin Pharmacol Ther2007
16537797Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier.J Pharmacol Exp Ther2006
16899784A proposal for radical changes in the drug-approval process.N Engl J Med2006
16952489The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity.Clin Pharmacol Ther2006
16513442Variations in the alpha2A-adrenergic receptor gene and their functional effects.Clin Pharmacol Ther2006
16672696Injury to research volunteers--the clinical-research nightmare.N Engl J Med2006
15944868Effect of acute transdermal estrogen administration on basal, mental stress and cold pressor-induced sympathetic responses in postmenopausal women.Clin Auton Res2005
16141387A sad day for science at the FDA.N Engl J Med2005
16382069Trial registration report card.N Engl J Med2005
15900214Variation in the alpha2B-adrenergic receptor gene (ADRA2B) and its relationship to vascular response in vivo.Pharmacogenet Genomics2005
15864122Alpha2B adrenergic receptor 301-303 deletion polymorphism and vascular alpha2 adrenergic receptor response.Pharmacogenet Genomics2005
14656950Alpha2-adrenergic receptor-induced vascular constriction in blacks and whites.Hypertension2004
15179408Alpha 1A-adrenergic receptor polymorphism and vascular response.Clin Pharmacol Ther2004
15284533Beta2-adrenoceptor Thr164Ile polymorphism is associated with markedly decreased vasodilator and increased vasoconstrictor sensitivity in vivo.Pharmacogenetics2004
14748820Sildenafil does not improve nitric oxide-mediated endothelium-dependent vascular responses in smokers.Br J Clin Pharmacol2004
15110896No association of the Asp298 variant of the endothelial nitric oxide synthase gene with preeclampsia.Am J Hypertens2004
  • 1 - 50 of 261

Recommended Authors

Bradley L Urquhart
Schulich School of Medicine and Dentistry, Western University
Career Start Year 2003
Number of shared co-authors 0
Matthias Schwab
and of Biochemistry and Pharmacy, University of Tuebingen
Career Start Year 1996
Number of shared co-authors 3
Carsten Skarke
University of Pennsylvania.
Career Start Year 1995
Number of shared co-authors 1
Stephen E Kimmel
University of Florida
Career Start Year 1995
Number of shared co-authors 2
Tilo Grosser
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1995
Number of shared co-authors 1
Deanna L Kroetz
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 3
Julie A Johnson
Department of Pharmacotherapy and Translational Research, University of Florida
Career Start Year 1992
Number of shared co-authors 3
Ali Serdar Fak
Marmara University, Hypertension and Atherosclerosis Research Center
Career Start Year 1992
Number of shared co-authors 0
Kazuhiro Kosuge
Center for Transformative AI and Robotics, Tohoku University
Career Start Year 1992
Number of shared co-authors 0
Robert J Walker
University of Otago
Career Start Year 1991
Number of shared co-authors 0
Bob L Lobo
Department of Pharmaceutical Services, Vanderbilt University Medical Center
Career Start Year 1988
Number of shared co-authors 0
Mark A Munger
Department of Pharmacotherapy, University of Utah Health
Career Start Year 1986
Number of shared co-authors 1
Scott J Weir
University of Kansas Medical Center
Career Start Year 1985
Number of shared co-authors 0
Paul B Watkins
UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill
Career Start Year 1984
Number of shared co-authors 3
Hartmut Hecker
Hannover Medical School
Career Start Year 1982
Number of shared co-authors 0
Debra A Schwinn
Roy J. & Lucille A. Carver College of Medicine, University of Iowa
Career Start Year 1981
Number of shared co-authors 1
Lawrence J Lesko
Department of Pharmaceutics, University of Florida
Career Start Year 1979
Number of shared co-authors 1
Kathleen M Giacomini
University of California San Francisco
Career Start Year 1978
Number of shared co-authors 2
Cameron G Swift
King's College London
Career Start Year 1978
Number of shared co-authors 0
Norman Stockbridge
Center for Drug Evaluation and Research
Career Start Year 1978
Number of shared co-authors 1
Jason G Umans
Georgetown and Howard Universities Center for Clinical and Translational Science
Career Start Year 1976
Number of shared co-authors 0
Michael Kutner
Emory University
Career Start Year 1976
Number of shared co-authors 1
Philip T Sager
Inc., Canada Cardiovascular Research Institute, Stanford University
Career Start Year 1975
Number of shared co-authors 1
Michael G Ziegler
University of California San Diego School of Medicine
Career Start Year 1973
Number of shared co-authors 1
Brian L Strom
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Career Start Year 1970
Number of shared co-authors 2
Richard L Byyny
Denver Health Medical Center, University of Colorado School of Medicine
Career Start Year 1969
Number of shared co-authors 0
Guilherme Suarez-Kurtz
Instituto Nacional de Cancer
Career Start Year 1968
Number of shared co-authors 1
Wolfgang Sad??e
College of Medicine, The Ohio State University
Career Start Year 1967
Number of shared co-authors 3
Pavel Hamet
Montreal University Hospital Research Center
Career Start Year 1967
Number of shared co-authors 0
Gopal Krishna
ICAR-Central Institute of Fisheries Education
Career Start Year 1964
Number of shared co-authors 0

Collaborators

Charles M Stein
Vanderbilt University School of Medicine
Co-authored papers 65
Grant R Wilkinson
1 Vanderbilt University Medical Center
Co-authored papers 41
Dan M Roden
Vanderbilt University Medical Center
Co-authored papers 15
Paul A Harris
School of Clinical Medicine, University of the Witwatersrand
Co-authored papers 11
David Robertson
Vanderbilt University Medical Center
Co-authored papers 9
Daniel W Byrne
Vanderbilt University Medical Center
Co-authored papers 5
Ian A Blair
Co-authored papers 4
Scott M Williams
Case Western Reserve University School of Medicine
Co-authored papers 4
Jonathan L Haines
Cleveland Institute for Computational Biology, Case Western Reserve University
Co-authored papers 3
Jack Uetrecht
Leslie Dan Faculty of Pharmacy and Faculty of Medicine, University of Toronto
Co-authored papers 2
Melanie M Wall
Co-authored papers 2
Garret A FitzGerald
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
Janet Andersen
Harvard School of Public Health
Co-authored papers 1
Kristine Coughlin
Frontier Science and Technology Research Foundation
Co-authored papers 1
Joseph Kannry
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Peter J Dempsey
University of Colorado
Co-authored papers 1
Harry P Selker
Tufts Clinical and Translational Science Institute (CTSI), Tufts University
Co-authored papers 1
Jo Anne Bennett
New York University
Co-authored papers 1
Daniel R Kuritzkes
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
Andy Stergachis
School of Pharmacy, University of Washington
Co-authored papers 1
Douglas D Richman
Center for AIDS Research, University of California San Diego
Co-authored papers 1
Margaret A Matula
Co-authored papers 1
Jody Lawrence
Inc., Collegeville
Co-authored papers 1
Cara Sutcliffe
Vanderbilt University
Co-authored papers 1
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 1
Ann Marshak-Rothstein
University of Massachusetts School of Medicine
Co-authored papers 1
Michael S Saag
University of Alabama at Birmingham
Co-authored papers 1
Eugene Wesley Ely
Vanderbilt University Medical Center
Co-authored papers 1
David W Haas
Vanderbilt University Medical Center
Co-authored papers 1
Janet Nicotera
Co-authored papers 1
Release 1.2